Anika Therapeutics to Present at Canaccord Genuity 34th Annual Growth Conference

Presentation to be Webcast Live at 10:30 a.m. ET

Canaccord Growth Conference 2014

BEDFORD, Mass.--()--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 10:30 a.m. ET. The conference is being held at the InterContinental Hotel in Boston, Massachusetts.

A live audio webcast of the presentation may be accessed via the “Investor Relations” section of Anika’s website at www.anikatherapeutics.com. An archive of the presentation also will be available on the website.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika's products range from orthopedic/joint health solutions led by Orthovisc® and Monovisc®, treatments for osteoarthritis of the knee, to surgical aids in the anti-adhesion and ophthalmic fields. The Company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika's Italian subsidiary, Anika Therapeutics S.r.l., provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in areas such as advanced wound treatment and ear, nose and throat care. Its regenerative technology advances Anika's vision to offer therapeutic products and medical solutions that go beyond pain relief to protect and restore damaged tissue.

Contacts

Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., President and CEO, 781-457-9000
or
Sylvia Cheung, CFO, 781-457-9000

Contacts

Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., President and CEO, 781-457-9000
or
Sylvia Cheung, CFO, 781-457-9000